Bard Associates’s inTEST INTT Stock Holding History

Bard Associates’s Portfolio INTT Stock Details INTT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Buy	211,586 +1,473	+0.7%	+$16.1K	0.72%	48
2025 Q4	$1.57M	Sell	210,113 -624	-0.3%	-$4.94K	0.4%	62
2025 Q3	$1.65M	Sell	210,737 -3,402	-2%	-$25K	0.44%	66
2025 Q2	$1.56M	Buy	214,139 +1,803	+0.8%	+$11.4K	0.5%	69
2025 Q1	$1.48M	Buy	212,336 +1,845	+0.9%	+$15.3K	0.55%	67
2024 Q4	$1.81M	Buy	210,491 +11,321	+6%	+$85.7K	0.61%	57
2024 Q3	$1.45M	Buy	199,170 +4,105	+2%	+$34.1K	0.5%	74
2024 Q2	$1.93M	Buy	195,065 +1,275	+0.7%	+$13.6K	0.74%	53
2024 Q1	$2.57M	Sell	193,790 -1,210	-0.6%	-$14.3K	0.92%	38
2023 Q4	$2.65M	Buy	195,000 +1,475	+0.8%	+$19.6K	1.01%	34
2023 Q3	$2.94M	Sell	193,525 -900	-0.5%	-$16.6K	1.22%	22
2023 Q2	$5.11M	Sell	194,425 -1,550	-0.8%	-$34.2K	1.98%	7
2023 Q1	$4.06M	Sell	195,975 -59,495	-23%	-$893K	1.68%	10
2022 Q4	$2.63M	Sell	255,470 -1,000	-0.4%	-$9.3K	1.13%	29
2022 Q3	$1.96M	Sell	256,470 -2,000	-0.8%	-$16.4K	0.88%	41
2022 Q2	$1.76M	Buy	258,470 +6,800	+3%	+$53.7K	0.76%	46
2022 Q1	$2.7M	Sell	251,670 -500	-0.2%	-$5.48K	0.95%	39
2021 Q4	$3.21M	Sell	252,170 -5,250	-2%	-$68K	1.05%	30
2021 Q3	$2.96M	Sell	257,420 -1,700	-0.7%	-$22.6K	1%	32
2021 Q2	$4.34M	Sell	259,120 -1,725	-0.7%	-$23.3K	1.42%	14
2021 Q1	$3.08M	Sell	260,845 -2,400	-0.9%	-$20.5K	1.11%	27
2020 Q4	$1.71M	Sell	263,245 -4,830	-2%	-$24.5K	0.67%	53
2020 Q3	$1.21M	Sell	268,075 -2,800	-1%	-$12.3K	0.64%	60
2020 Q2	$913K	Sell	270,875 -10,500	-4%	-$33.4K	0.51%	75
2020 Q1	$748K	Sell	281,375 -600	-0.2%	-$2.87K	0.55%	70
2019 Q4	$1.68M	Sell	281,975 -2,100	-0.7%	-$11.1K	0.85%	44
2019 Q3	$1.32M	Sell	284,075 -7,000	-2%	-$31.4K	0.67%	60
2019 Q2	$1.4M	Sell	291,075 -1,600	-0.5%	-$9.22K	0.7%	54
2019 Q1	$1.97M	Sell	292,675 -3,500	-1%	-$25.2K	0.99%	29
2018 Q4	$1.82M	Sell	296,175 -8,900	-3%	-$61K	1.05%	24
2018 Q3	$2.36M	Sell	305,075 -1,500	-0.5%	-$12.1K	1.09%	25
2018 Q2	$2.24M	Sell	306,575 -2,935	-0.9%	-$20.8K	1.04%	22
2018 Q1	$2.06M	Sell	309,510 -21,550	-7%	-$178K	1.03%	26
2017 Q4	$2.86M	Sell	331,060 -7,730	-2%	-$68.6K	1.37%	17
2017 Q3	$2.81M	Sell	338,790 -4,000	-1%	-$30.3K	1.31%	18
2017 Q2	$2.28M	Sell	342,790 -2,250	-0.7%	-$16.4K	1.03%	26
2017 Q1	$2.21M	Sell	345,040 -3,500	-1%	-$18.1K	1.03%	25
2016 Q4	$1.6M	Buy	348,540 +2,605	+0.8%	+$10.9K	0.74%	48
2016 Q3	$1.38M	Sell	345,935 -6,330	-2%	-$24.6K	0.68%	57
2016 Q2	$1.34M	Sell	352,265 -2,720	-0.8%	-$10.6K	0.71%	55
2016 Q1	$1.38M	Buy	354,985 +6,750	+2%	+$27K	0.8%	43
2015 Q4	$1.47M	Sell	348,235 -26,900	-7%	-$105K	0.87%	37
2015 Q3	$1.58M	Sell	375,135 -7,600	-2%	-$31.5K	0.91%	37
2015 Q2	$1.67M	Sell	382,735 -12,050	-3%	-$54.5K	0.83%	45
2015 Q1	$1.62M	Sell	394,785 -4,950	-1%	-$20.5K	0.78%	50
2014 Q4	$1.7M	Sell	399,735 -1,000	-0.2%	-$4.37K	0.79%	46
2014 Q3	$1.91M	Sell	400,735 -2,300	-0.6%	-$10.6K	0.89%	40
2014 Q2	$1.57M	Sell	403,035 -3,000	-0.7%	-$11.8K	0.62%	61
2014 Q1	$1.63M	Sell	406,035 -800	-0.2%	-$3.17K	0.69%	55
2013 Q4	$1.55M	Sell	406,835 -5,150	-1%	-$19.8K	0.64%	58
2013 Q3	$1.63M	Sell	411,985 -1,300	-0.3%	-$5.14K	0.72%	43
2013 Q2	$1.57M	Buy	+413,285	New	+$1.35M	0.73%	50

Other funds holding INTT

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bard Associates's INTT Position: Q1 2026 in Review

Bard Associates increased its inTEST (INTT) stake by 0.7% in Q1 2026, buying an estimated $16.1K and bringing the position to 211,586 shares worth $2.89M. The position accounts for 0.72% of the portfolio, ranked #48.

Bard Associates first reported a position in INTT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.11M in Q2 2023. 75 funds tracked by Wall St. Rank hold INTT as of Q1 2026.

Bard Associates held 211,586 shares of inTEST worth $2.89M as of Q1 2026.
Bard Associates bought 1,473 inTEST shares in Q1 2026, an estimated $16.1K.
inTEST made up 0.72% of Bard Associates's portfolio in Q1 2026, its #48 holding.
Bard Associates first reported a position in inTEST in Q2 2013 and has held it in 52 quarters since.
Bard Associates's inTEST position peaked at $5.11M in Q2 2023.
75 funds tracked by Wall St. Rank held inTEST as of Q1 2026.

Based on Bard Associates's 13F filing for Q1 2026, filed 8 May 2026.